Navidea Biopharma (NAVB) Confirms it Won Platinum Litigation
Navidea Biopharma (NYSE: NAVB) disclosed in an SEC filing:On October 31, 2018, Judge Valerie Caproni of the United States District ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)